PRMA Consulting - Building a healthier Asia

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

31

Jan 2023

Charles River Completes Acquisition of SAMDI Tech

Charles River announced the acquisition of SAMDI Tech The acquisition is the culmination of an exclusive partnership between the companies started in The acquisition of SAMDI Techs cuttingedge highthroughput screening technology further strengthens Charles Rivers drug discovery

31

Jan 2023

Sun Pharma Acquires Disperzyme® And Phlogam® Brands

Sun Pharmaceutical announced that it has acquired three brands viz Disperzyme Trypsin BP mg Bromelain mg Rutoside Trihydrate mg DisperzymeCD Trypsin BP mg Bromelain mg Rutoside Trihydrate mg and Phlogam Trypsin BP mg Bromelain mg Rutoside Trihydrate mg from Aksigen

31

Jan 2023

Xeris Biopharma Grants FDA Orphan-drug Exclusivity for Recorlev®

Xeris Biopharma Holdings announced that the Food and Drug Administration FDA granted its subsidiary Xeris Pharmaceuticals orphandrug exclusivity ODE for Recorlev levoketoconazole for the treatment of adult patients with endogenous Cushings syndrome where surgery is not possible or resulted uncurable

30

Jan 2023

Dupixent® (Dupilumab) Approved as The First And Only Targeted Medicine For Eosinophilic Oesophagitis

The European Commission EC has expanded the marketing authorisation for Dupixent dupilumab in the European Union EU to treat eosinophilic oesophagitis EoE in adults and adolescents years and older weighing at least kg for those inadequately controlled by are intolerant to or who are not candidates

27

Jan 2023

Roche Launches COVID-19 PCR Test for Omicron Sub-Variant

Roche and its subsidiary TIB Molbiol developed a COVID PCR test for researchers to detect and differentiate the latest variant of concern XBB The XBB variant is prevalent in the United States and is quickly spreading to other countries Being able to differentiate emerging variants and understand the...

27

Jan 2023

Evotec Enters into Agreement with Janssen

Evotec SE announced a strategic collaboration and licence agreement with Janssen Biotech Inc Janssen one of the Janssen Pharmaceutical Companies of Johnson Johnson The collaboration mainly focuses on the development of firstinclass targeted immunebased therapies

press releasesRead more...

30

Jan 2023

Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease

Nanoscope Therapeutics Inc a clinicalstage biotechnology company developing gene therapies for retinal degenerative diseases today announced that the US Food and Drug Administration FDA has granted Fast Track Designation FTD to MCO an ambientlight activatable MultiCharacteristic Opsin MCO optogeneti...

30

Jan 2023

Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar

Sandoz a global leader in offpatent generic and biosimilar medicines today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion for marketing authorization for a citratefree high concentration formulation HCF of it...

30

Jan 2023

Teijin Pharma to Launch Japan-market Sales of Abaloparatide Acetate for Osteoporos

Teijin Pharma Limited the core company of the Teijin Groups healthcare business announced today that on January the company will begin selling abaloparatide acetate for osteoporosis under the tradename OSTABALO Subcutaneous Injection Cart mg will be priced at JPY

30

Jan 2023

Lecanemab Receives Priority Review Status In Japan

Eisai Co Ltd and Biogen Inc announced today that an application for manufacturing and marketing approval for lecanemab generic name US brand name LEQEMBI an antiamyloid A protofibril antibody in Japan has been designated for Priority Review by the Japanese Ministry of Health Labour and Welfare

30

Jan 2023

Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer

Ribon Therapeutics a clinicalstage biotechnology company developing therapeutics to target stress support pathways today announced a million investment from Pfizer Ribon plans to use the proceeds to support clinical development of its potentially firstinclass oral small molecule programs in oncolog...

30

Jan 2023

GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery

Throughout GeneDx a leader in delivering improved health outcomes through genomic and clinical insights contributed a significant amount of total candidate gene submissions to GeneMatcher a platform that facilitates new disease gene discovery and enables connections between patients clinicians a...

EventsRead more...

30 - 01

Jan 2023

Precision Medicine in Inflammatory

Hanson Wade
Embassy Suites by Hilton Boston

31 - 02

Jan 2023

Viral Vector Process Development

Hanson Wade
Omni Parker House

08 - 09

Feb 2023

RNA Therapeutics Conference

SAE Media group
Copthorne Tara Hotel London Kensington

14 - 16

Feb 2023

CRISPR AgBio Congress 2023

Hanson Wade
The Westin San Diego Bayview

14 - 16

Feb 2023

mRNA Analytical Development

Hanson Wade
Hyatt Regency Boston

21 - 23

Feb 2023

5th Bacteriophage Therapy Summit

Hanson Wade
Virtual Event

21 - 23

Feb 2023

Retinal Vascular Disease Drug Development

Hanson Wade
Hilton Boston Logan Airport

13 - 14

Mar 2023

TOP ARTICLES

  • 4

    Futuristic Application of Human-On-A-Chip Technology

    Joseph Xavier

    Pursuing PhD, Division of Toxicology, SCTIMST

    Akhil Venugopal

    Junior Research Fellow, Division of Toxicology, SCTIMST

    Arathi Ashok

    Junior Research Fellow, Division of Toxicology, SCTIMST

    PV. Mohanan

    Scientist-G and Head of Division of Toxicology and Associate Dean, SCTIMST

KNOWLEDGE BANK

  • Interviews

    European Lead Factory

    Head of European Screening Centre

    Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature
  • Articles

    Analysis of Blood Microbiota Compositionin Cardiovascular Disease Patients

    Cardiovascular diseases CVDs are now the leading cause of morbidity and mortality worldwide Khan et al Despite substantial breakthroughs in prevention fast detection and treatment CVDs continue to place a significant socioeconomic burden on health systems and communities CVDs prevalence has risen by and mortality has risen by accounting for more

  • Techno Trends

    Painless Needle-free Injections - Micro-Jets

    Injections will be pain free with MicroJets a novel injector system a needlefree drug delivery system developed by a team of researchers from University of California in collaboration with StratGent Life Sciences This novel needlefree injection would increase patient comfort while eliminating the risk to healthcare workers from needlestick injuries by delivering macro...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...